{"count": 12, "results": [{"_id": "21644841", "pmid": 21644841, "title": "The enhanced effect of atenolol on hypertension in metabolic syndrome.", "journal": "Metab Syndr Relat Disord", "authors": ["Ueno N", "Satou Y"], "date": "2011-10-01T00:00:00Z", "doi": "10.1089/met.2011.0001", "meta_date_publication": "2011 Oct", "meta_volume": "9", "meta_issue": "5", "meta_pages": "369-73", "score": 50076.867, "text_hl": "The enhanced effect of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@.", "citations": {"NLM": "Ueno N, Satou Y. The enhanced effect of atenolol on hypertension in metabolic syndrome. Metab Syndr Relat Disord. 2011 Oct;9(5):369-73. PMID: 21644841", "BibTeX": "@article{21644841, title={The enhanced effect of atenolol on hypertension in metabolic syndrome.}, author={Ueno N and Satou Y}, journal={Metab Syndr Relat Disord}, volume={9}, number={5}, pages={369-73}}"}}, {"_id": "9315593", "pmid": 9315593, "title": "Effect of atenolol on QT interval and dispersion in patients with syndrome X.", "journal": "Am J Cardiol", "authors": ["Leonardo F", "Fragasso G", "Rosano GM", "Pagnotta P", "Chierchia SL"], "date": "1997-09-15T00:00:00Z", "doi": "10.1016/s0002-9149(97)00519-5", "meta_date_publication": "1997 Sep 15", "meta_volume": "80", "meta_issue": "6", "meta_pages": "789-90", "score": 50075.047, "text_hl": "Effect of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on QT interval and dispersion in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@syndrome X", "citations": {"NLM": "Leonardo F, Fragasso G, Rosano GM, Pagnotta P, Chierchia SL. Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol. 1997 Sep 15;80(6):789-90. PMID: 9315593", "BibTeX": "@article{9315593, title={Effect of atenolol on QT interval and dispersion in patients with syndrome X.}, author={Leonardo F and Fragasso G and Rosano GM and Pagnotta P and Chierchia SL}, journal={Am J Cardiol}, volume={80}, number={6}, pages={789-90}}"}}, {"_id": "10687257", "pmid": 10687257, "title": "Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.", "journal": "Cardiologia", "authors": ["Leonardo F", "Fragasso G", "Rossetti E", "Dabrowski P", "Pagnotta P", "Rosano GM", "Chierchia SL"], "date": "1999-12-01T00:00:00Z", "meta_date_publication": "1999 Dec", "meta_volume": "44", "meta_issue": "12", "meta_pages": "1065-9", "score": 50064.24, "text_hl": "Comparison of @CHEMICAL_Trimetazidine @CHEMICAL_MESH:D014292 @@@trimetazidine@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@syndrome X@@@: effects on diastolic function and exercise tolerance.", "citations": {"NLM": "Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance. Cardiologia. 1999 Dec;44(12):1065-9. PMID: 10687257", "BibTeX": "@article{10687257, title={Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.}, author={Leonardo F and Fragasso G and Rossetti E and Dabrowski P and Pagnotta P and Rosano GM and Chierchia SL}, journal={Cardiologia}, volume={44}, number={12}, pages={1065-9}}"}}, {"_id": "10513787", "pmid": 10513787, "title": "Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.", "journal": "Am J Cardiol", "authors": ["Lanza GA", "Colonna G", "Pasceri V", "Maseri A"], "date": "1999-10-01T00:00:00Z", "doi": "10.1016/s0002-9149(99)00450-6", "meta_date_publication": "1999 Oct 1", "meta_volume": "84", "meta_issue": "7", "meta_pages": "854-6, A8", "score": 50059.32, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ versus @CHEMICAL_isosorbide_5_mononitrate @CHEMICAL_MESH:C030397 @@@isosorbide-5-mononitrate@@@ on @DISEASE_Signs_and_Symptoms @DISEASE_MESH:D012816 @@@anginal symptoms@@@ in @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@syndrome X", "citations": {"NLM": "Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999 Oct 1;84(7):854-6, A8. PMID: 10513787", "BibTeX": "@article{10513787, title={Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.}, author={Lanza GA and Colonna G and Pasceri V and Maseri A}, journal={Am J Cardiol}, volume={84}, number={7}, pages={854-6, A8}}"}}, {"_id": "15924807", "pmid": 15924807, "title": "[A clinical intervention study among 463 essential hypertensive patients with metabolic syndrome].", "journal": "Zhonghua Xin Xue Guan Bing Za Zhi", "authors": ["Guo JZ", "Gong YC", "Zhang JL", "Qing YW", "Dai QY", "Wang YC", "Gao X", "Ni YF"], "date": "2005-02-01T00:00:00Z", "meta_date_publication": "2005 Feb", "meta_volume": "33", "meta_issue": "2", "meta_pages": "132-6", "score": 50054.75, "text_hl": "Two of the three components (1) increased waist circumference and/or BMI; (2) increased @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglycerides@@@ (@CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@TG@@@) and/or decreased high-density lipoprotein cholesterol; (3) @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ (@DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@IGT@@@) were present define the @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@MS@@@. The three intervention therapy groups were: @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@ + @CHEMICAL_Fosinopril @CHEMICAL_MESH:D017328 @@@fosinopril@@@ (I + F, n = 151); @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ + @CHEMICAL_Nitrendipine @CHEMICAL_MESH:D009568 @@@nitrendipine@@@ (A + N, n = 160); @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ + @CHEMICAL_Nitrendipine @CHEMICAL_MESH:D009568 @@@nitrendipine@@@ + @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (A + N + M, n = 152). ", "citations": {"NLM": "Guo JZ, Gong YC, Zhang JL, Qing YW, Dai QY, Wang YC, Gao X, Ni YF. [A clinical intervention study among 463 essential hypertensive patients with metabolic syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):132-6. PMID: 15924807", "BibTeX": "@article{15924807, title={[A clinical intervention study among 463 essential hypertensive patients with metabolic syndrome].}, author={Guo JZ and Gong YC and Zhang JL and Qing YW and Dai QY and Wang YC and Gao X and Ni YF}, journal={Zhonghua Xin Xue Guan Bing Za Zhi}, volume={33}, number={2}, pages={132-6}}"}}, {"_id": "23819342", "pmid": 23819342, "title": "[Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].", "journal": "Ter Arkh", "authors": ["Kalyuzhin VV", "Teplyakov AT", "Pushnikova EY", "Bespalova LD", "Kalyuzhina EV", "Kolesnikov RN"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013", "meta_volume": "85", "meta_issue": "5", "meta_pages": "68-72", "score": 50052.742, "text_hl": "[Comparative evaluation of the impact of four-week therapy with @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on quality of life and blood @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ composition in @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@ associated with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@].", "citations": {"NLM": "Kalyuzhin VV, Teplyakov AT, Pushnikova EY, Bespalova LD, Kalyuzhina EV, Kolesnikov RN. [Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. Ter Arkh. 2013;85(5):68-72. PMID: 23819342", "BibTeX": "@article{23819342, title={[Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].}, author={Kalyuzhin VV and Teplyakov AT and Pushnikova EY and Bespalova LD and Kalyuzhina EV and Kolesnikov RN}, journal={Ter Arkh}, volume={85}, number={5}, pages={68-72}}"}}, {"_id": "9038691", "pmid": 9038691, "title": "Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade.", "journal": "Heart", "authors": ["Fragasso G", "Chierchia SL", "Pizzetti G", "Rossetti E", "Carlino M", "Gerosa S", "Carandente O", "Fedele A", "Cattaneo N"], "date": "1997-01-01T00:00:00Z", "doi": "10.1136/hrt.77.1.32", "meta_date_publication": "1997 Jan", "meta_volume": "77", "meta_issue": "1", "meta_pages": "32-9", "score": 50052.203, "text_hl": "OBJECTIVE: To assess exercise performance and @DISEASE_Ventricular_Dysfunction_Left @DISEASE_MESH:D018487 @@@resting left ventricular filling@@@ dynamics in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@syndrome X@@@ (@<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@SX@@@) in basal conditions and after 10 days treatment with oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Fragasso G, Chierchia SL, Pizzetti G, Rossetti E, Carlino M, Gerosa S, Carandente O, Fedele A, Cattaneo N. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade. Heart. 1997 Jan;77(1):32-9. PMID: 9038691", "BibTeX": "@article{9038691, title={Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade.}, author={Fragasso G and Chierchia SL and Pizzetti G and Rossetti E and Carlino M and Gerosa S and Carandente O and Fedele A and Cattaneo N}, journal={Heart}, volume={77}, number={1}, pages={32-9}}"}}, {"_id": "20411618", "pmid": 20411618, "title": "Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.", "journal": "J Hypertens", "authors": ["Toblli J", "Cao G", "Rivas C", "Munoz M", "Giani J", "Dominici F", "Angerosa M"], "date": "2010-05-01T00:00:00Z", "doi": "10.1097/hjh.0b013e328337598c", "meta_date_publication": "2010 May", "meta_volume": "28", "meta_issue": "5", "meta_pages": "1007-19", "score": 50050.242, "text_hl": "CONCLUSION: The present study provides substantial information supporting an actual protective role of @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ in comparison with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in experimental @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@.", "citations": {"NLM": "Toblli J, Cao G, Rivas C, Munoz M, Giani J, Dominici F, Angerosa M. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens. 2010 May;28(5):1007-19. PMID: 20411618", "BibTeX": "@article{20411618, title={Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.}, author={Toblli J and Cao G and Rivas C and Munoz M and Giani J and Dominici F and Angerosa M}, journal={J Hypertens}, volume={28}, number={5}, pages={1007-19}}"}}, {"_id": "12891253", "pmid": 12891253, "title": "[Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome].", "journal": "Kardiologiia", "authors": ["Mamedov MN", "Perova NV", "Kosmatova OV", "Khadipash LA", "Kiseleva NV", "Oganov RG"], "date": "2003-01-01T00:00:00Z", "meta_date_publication": "2003", "meta_volume": "43", "meta_issue": "3", "meta_pages": "13-9", "score": 50049.742, "text_hl": "MATERIAL: Seventy five @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ aged 40-59 years were included into an open study with parallel groups in which the following combinations of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering and antihypertensive drugs were used for sweeksinch: @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ + @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ (n=17, group 1); @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ + @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (n=17, group 2); @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ + @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (n=21, group 3), and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ + @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@ (n=20, group 4). ", "citations": {"NLM": "Mamedov MN, Perova NV, Kosmatova OV, Khadipash LA, Kiseleva NV, Oganov RG. [Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome]. Kardiologiia. 2003;43(3):13-9. PMID: 12891253", "BibTeX": "@article{12891253, title={[Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome].}, author={Mamedov MN and Perova NV and Kosmatova OV and Khadipash LA and Kiseleva NV and Oganov RG}, journal={Kardiologiia}, volume={43}, number={3}, pages={13-9}}"}}, {"_id": "17433471", "pmid": 17433471, "title": "Are we misunderstanding beta-blockers.", "journal": "Int J Cardiol", "authors": ["Cruickshank JM"], "date": "2007-08-09T00:00:00Z", "doi": "10.1016/j.ijcard.2007.01.069", "meta_date_publication": "2007 Aug 9", "meta_volume": "120", "meta_issue": "1", "meta_pages": "10-27", "score": 50041.277, "text_hl": "Conversely, in elderly @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensives@@@ first-line beta-blockade (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) has performed poorly in reducing cardiovascular risk (due to partial beta-2 blockade @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ evokes @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic disturbance@@@ and does not improve vascular compliance, or effectively lower central aortic pressure or reverse @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@). ", "citations": {"NLM": "Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol. 2007 Aug 9;120(1):10-27. PMID: 17433471", "BibTeX": "@article{17433471, title={Are we misunderstanding beta-blockers.}, author={Cruickshank JM}, journal={Int J Cardiol}, volume={120}, number={1}, pages={10-27}}"}}]}